These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 27437883

  • 21. Novel antidiabetic drugs and cardiovascular risk: Primum non nocere.
    Bonadonna RC, Borghi C, Consoli A, Volpe M.
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):759-66. PubMed ID: 27373139
    [Abstract] [Full Text] [Related]

  • 22. Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
    Alfredsson J, Green JB, Stevens SR, Reed SD, Armstrong PW, Angelyn Bethel M, Engel SS, McGuire DK, Van de Werf F, Hramiak I, White HD, Peterson ED, Holman RR, TECOS Study Group.
    Diabetes Obes Metab; 2018 Oct; 20(10):2379-2388. PubMed ID: 29923323
    [Abstract] [Full Text] [Related]

  • 23. Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
    Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK, CARMELINA Investigators.
    JAMA; 2019 Jan 01; 321(1):69-79. PubMed ID: 30418475
    [Abstract] [Full Text] [Related]

  • 24. Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS.
    Cornel JH, Bakris GL, Stevens SR, Alvarsson M, Bax WA, Chuang LM, Engel SS, Lopes RD, McGuire DK, Riefflin A, Rodbard HW, Sinay I, Tankova T, Wainstein J, Peterson ED, Holman RR, TECOS Study Group.
    Diabetes Care; 2016 Dec 01; 39(12):2304-2310. PubMed ID: 27742728
    [Abstract] [Full Text] [Related]

  • 25. Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.
    Fudim M, White J, Pagidipati NJ, Lokhnygina Y, Wainstein J, Murin J, Iqbal N, Öhman P, Lopes RD, Reicher B, Holman RR, Hernandez AF, Mentz RJ.
    Circulation; 2019 Nov 12; 140(20):1613-1622. PubMed ID: 31542942
    [Abstract] [Full Text] [Related]

  • 26. Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
    Reed SD, Li Y, Leal J, Radican L, Adler AI, Alfredsson J, Buse JB, Green JB, Kaufman KD, Riefflin A, Van de Werf F, Peterson ED, Gray AM, Holman RR, TECOS Study Group.
    Diabetes Obes Metab; 2018 Jul 12; 20(7):1732-1739. PubMed ID: 29573215
    [Abstract] [Full Text] [Related]

  • 27. Restricted Mean Survival Time Analysis to Estimate SGLT2i-Associated Heterogeneous Treatment Effects on Primary and Secondary Prevention of Cardiorenal Outcomes in Patients With Type 2 Diabetes in Taiwan.
    Peng ZY, Yang CT, Kuo S, Wu CH, Lin WH, Ou HT.
    JAMA Netw Open; 2022 Dec 01; 5(12):e2246928. PubMed ID: 36520437
    [Abstract] [Full Text] [Related]

  • 28. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
    Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP, ASTRONAUT Investigators and Coordinators.
    JAMA; 2013 Mar 20; 309(11):1125-35. PubMed ID: 23478743
    [Abstract] [Full Text] [Related]

  • 29. Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.
    Sharma A, Green JB, Dunning A, Lokhnygina Y, Al-Khatib SM, Lopes RD, Buse JB, Lachin JM, Van de Werf F, Armstrong PW, Kaufman KD, Standl E, Chan JCN, Distiller LA, Scott R, Peterson ED, Holman RR, TECOS Study Group.
    Diabetes Care; 2017 Dec 20; 40(12):1763-1770. PubMed ID: 28986504
    [Abstract] [Full Text] [Related]

  • 30. Cardiovascular and Renal Outcomes With Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors Combination Therapy: A Meta-Analysis of Randomized Cardiovascular Outcome Trials.
    Singh AK, Singh A, Singh R.
    Endocr Pract; 2023 Jul 20; 29(7):509-516. PubMed ID: 37037286
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Oyama K, Raz I, Cahn A, Goodrich EL, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Gause-Nilsson IAM, Mosenzon O, Sabatine MS, Wiviott SD.
    JAMA Cardiol; 2022 Sep 01; 7(9):914-923. PubMed ID: 35857296
    [Abstract] [Full Text] [Related]

  • 32. Association Between Hospitalization for Heart Failure and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes: An Observational Study.
    Fu AZ, Johnston SS, Ghannam A, Tsai K, Cappell K, Fowler R, Riehle E, Cole AL, Kalsekar I, Sheehan J.
    Diabetes Care; 2016 May 01; 39(5):726-34. PubMed ID: 26740636
    [Abstract] [Full Text] [Related]

  • 33. Sitagliptin and the risk of hospitalization for heart failure: a population-based study.
    Wang KL, Liu CJ, Chao TF, Huang CM, Wu CH, Chen SJ, Yeh CM, Chen TJ, Lin SJ, Chiang CE.
    Int J Cardiol; 2014 Nov 15; 177(1):86-90. PubMed ID: 25499347
    [Abstract] [Full Text] [Related]

  • 34. Higher-Dose Sitagliptin and the Risk of Congestive Heart Failure in Older Adults with CKD.
    Muanda FT, Weir MA, Bathini L, Clemens KK, Perkovic V, Sood MM, McArthur E, Sontrop JM, Kim RB, Garg AX.
    Clin J Am Soc Nephrol; 2020 Dec 07; 15(12):1728-1739. PubMed ID: 33239410
    [Abstract] [Full Text] [Related]

  • 35. International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS.
    Bhatt AS, Luo N, Solomon N, Pagidipati NJ, Ambrosio G, Green JB, McGuire DK, Standl E, Cornel JH, Halvorsen S, Lopes RD, White HD, Holman RR, Peterson ED, Mentz RJ, TECOS Study Group.
    Am Heart J; 2019 Dec 07; 218():57-65. PubMed ID: 31707329
    [Abstract] [Full Text] [Related]

  • 36. Oral hypoglycemic agents and the heart failure conundrum: Lessons from and for outcome trials.
    Kappel BA, Marx N, Federici M.
    Nutr Metab Cardiovasc Dis; 2015 Aug 07; 25(8):697-705. PubMed ID: 26164634
    [Abstract] [Full Text] [Related]

  • 37. Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.
    McAlister FA, Zheng Y, Westerhout CM, Buse JB, Standl E, McGuire DK, Van de Werf F, Green JB, Armstrong PW, Holman RR, TECOS Study Group.
    Eur J Heart Fail; 2020 Nov 07; 22(11):2026-2034. PubMed ID: 32621557
    [Abstract] [Full Text] [Related]

  • 38. Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study.
    Eurich DT, Weir DL, Simpson SH, Senthilselvan A, McAlister FA.
    Diabet Med; 2016 May 07; 33(5):621-30. PubMed ID: 26206341
    [Abstract] [Full Text] [Related]

  • 39. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.
    Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, Davidson J, Steg PG, Bhatt DL, SAVOR-TIMI 53 Steering Committee and Investigators*.
    Circulation; 2014 Oct 28; 130(18):1579-88. PubMed ID: 25189213
    [Abstract] [Full Text] [Related]

  • 40. Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.
    Green JB, Bethel MA, Paul SK, Ring A, Kaufman KD, Shapiro DR, Califf RM, Holman RR.
    Am Heart J; 2013 Dec 28; 166(6):983-989.e7. PubMed ID: 24268212
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.